<DOC>
	<DOC>NCT00928551</DOC>
	<brief_summary>This study will compare two different formulations of vabicaserin.</brief_summary>
	<brief_title>Comparative Formulation Study of Vabicaserin</brief_title>
	<detailed_description />
	<criteria>Sexually active men must agree to use a medically acceptable form of contraception during the study and continue it for 12 weeks after investigational product administration. Nonsmoker or smoker of fewer than 10 cigarettes per day as determined by history. Must be able to abstain from smoking during the inpatient stay. Use of any investigational or prescription drug within 30 days before investigation product administration. Consumption of any caffeinecontaining products (eg, coffee, tea, chocolate, or soda) or alcoholic beverages within 48 hours before study day 1. Use of any overthecounter drugs, including herbal supplements within 72 hours before study day 1.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>